ResearcherMayo ClinicActive in the last 2 years
Pashtoon Murtaza Kasi
Matched on ORCID iD 0000-0002-5169-7085; OpenAlex author ID A5077416215. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 2, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 53
2015: 1 paper · 2016: none · 2017: none · 2018: 3 papers · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 12
- Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial. Co-author DOI 10.1038/s41591-026-04734-7↗
- Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Co-author DOI 10.1093/oncolo/oyae155↗
- Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer. Last author DOI 10.1136/jitc-2021-004485↗
- Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1002/onco.13717↗
- Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. First author DOI 10.1158/1078-0432.ccr-20-1788↗
- Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer. Last author DOI 10.1186/s13053-020-00148-9↗
- Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer. Last author DOI 10.3389/fphar.2020.00023↗
- Outcomes in patients with DNA-damage repair related pancreatic cancer Last author DOI 10.21203/rs.2.10012/v1↗
- Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. Co-author DOI 10.1001/jama.2018.6228↗
- Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. First author DOI 10.3389/fonc.2018.00330↗
- Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma. Last author DOI 10.3389/fphar.2018.01309↗
- BRCA2‐associated pancreatic cancer and current screening guidelines Co-author DOI 10.1002/cncr.29447↗
Closest collaborators
The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Naomi H. Fei · 3 shared papers, 2022–2026 · strength 0.49
- Paper Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial. DOI 10.1038/s41591-026-04734-7↗
- Paper Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunothe… DOI 10.1136/jitc-2021-004485↗
- Paper Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. DOI 10.1093/oncolo/oyae155↗
- Stephanie L. Hines · 3 shared papers, 2018–2020 · strength 0.47
- Paper Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer. DOI 10.1186/s13053-020-00148-9↗
- Paper Outcomes in patients with DNA-damage repair related pancreatic cancer DOI 10.21203/rs.2.10012/v1↗
- Paper Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. DOI 10.3389/fonc.2018.00330↗
- Tanios Bekaii‐Saab · 2 shared papers, 2021–2026 · strength 0.30
- Paper Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial. DOI 10.1038/s41591-026-04734-7↗
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Sarah Macklin · 2 shared papers, 2018–2019 · strength 0.28
- Jason Scott Starr · 2 shared papers, 2021–2022 · strength 0.26
- Paper Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunothe… DOI 10.1136/jitc-2021-004485↗
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Robert R. McWilliams · 3 shared papers, 2015–2020 · strength 0.24
- Paper Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic A… DOI 10.1158/1078-0432.ccr-20-1788↗
- Paper BRCA2‐associated pancreatic cancer and current screening guidelines DOI 10.1002/cncr.29447↗
- Paper Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. DOI 10.1001/jama.2018.6228↗
- Harshabad Singh · 1 shared paper, 2026 · strength 0.19
- Zev A. Wainberg · 1 shared paper, 2026 · strength 0.19
- Jennifer Brooke Valerin · 1 shared paper, 2026 · strength 0.19
- Alexis Diane Leal · 1 shared paper, 2026 · strength 0.19
- Andrew Eugene Hendifar · 1 shared paper, 2026 · strength 0.19
- Craig Devoe · 1 shared paper, 2026 · strength 0.19
- Syed Mohammad Ali Kazmi · 1 shared paper, 2026 · strength 0.19
- Jonathan D. Mizrahi · 1 shared paper, 2026 · strength 0.19
- Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.19
- Ben George · 1 shared paper, 2026 · strength 0.19
- Peter J. Hosein · 1 shared paper, 2026 · strength 0.19
- Manuel M. Hidalgo · 1 shared paper, 2026 · strength 0.19
- Dana Backlund Cardin · 1 shared paper, 2026 · strength 0.19
- Thomas J. George · 1 shared paper, 2026 · strength 0.19
- Vincent M. Chung · 1 shared paper, 2026 · strength 0.19
- Mark H. O’Hara · 1 shared paper, 2026 · strength 0.19
- Colin D. Weekes · 1 shared paper, 2026 · strength 0.19
- Shubham Pant · 1 shared paper, 2026 · strength 0.19
- Sarah K. Macklin‐Mantia · 1 shared paper, 2020 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.